Fierce Biotech Names Accent Therapeutics as One of Its “Fierce 15” Biotech Companies of 2020
(WorldNews Health)

LEXINGTON, Mass.--(BUSINESS WIRE)--Sep 28, 2020-- Accent Therapeutics today announced that it has been named by Fierce Biotech as one of 2020`s Fierce 15 biotechnology companies, designating it as one of the most promising private biotechnology companies in the industry. Accent is a leader in the development of small molecule therapies that selectively inhibit RNA-modifying proteins (RMPs) that drive cancer. By targeting RMPs, the company is taking a novel approach to unlocking the potential of RNA biology by targeting enzymes responsible for post-transcriptional chemical modifications of RNA. Accent is developing a rich pipeline of oncology-focused therapies in a new class of medicines that...